Table 1.
Antimicrobials | Method | MIC [μg mL−1] | |||
---|---|---|---|---|---|
00‐1597 | 00‐6200 | 00‐0949 | 01‐1512 | ||
Azithromycina | CAMPY panel (Trek) | 0.06 | 0.06 | 0.06 | 0.06 |
Ciprofloxacinb | 16 | 0.06 | 0.06 | 0.06 | |
Clindamycina | 0.5 | 0.12 | 0.12 | 0.12 | |
Erythromycinb | 1 | 0.5 | 0.5 | 0.5 | |
Florfenicola | 2 | 1 | 1 | 1 | |
Gentamicina | 1 | 0.5 | 0.5 | 0.5 | |
Nalidixic acida | > 64 | ≤4 | ≤4 | ≤4 | |
Telithromycina | 1 | 2 | 0.5 | 0.5 | |
Tetracyclineb | 0.5 | 0.12 | > 64 | 64 | |
Ampicillin | ETest | 1.5 | 1 | 2 | 64c |
Amox/clav | 0.75 | 0.75 | 1 | 4 |
C. jejuni isolates categorized as phenotypically resistant are bold and underlined.
NARMS interpretation.
CLSI M45 interpretation.
MIC > 30‐fold increase.